Salesforce is transitioning from a hyper-growth SaaS pioneer to a mature compounder. The thesis centers on a strategic shift from dilutive M&A to disciplined capital allocation, margin expansion, and robust free cash flow generation. Fair value range: low $172, high $303, with mid-point at $237.
Key risk is a return to undisciplined M&A or high SBC dilution.
Fair value
$237
Margin of safety
+23.3%
Confidence
88/100
Moat
9/10
Educational analysis only — not financial advice. Always do your own due diligence.
$181.82Price
Low $171.93
Mid $236.95
High $303.18
Salesforce is transitioning from a hyper-growth SaaS pioneer to a mature compounder. The thesis centers on a strategic shift from dilutive M&A to disciplined capital allocation, margin expansion, and robust free cash flow generation.
High switching costs within core
High switching costs within core enterprise ecosystem
Deep integration of multi-cloud CRM
Deep integration of multi-cloud CRM software
Cycle upside
AI-driven product cycles reignite enterprise IT software spending.
CRM (CRM)'s revenue growth is reported year-over-year across the most recent five fiscal years, with the deceleration or acceleration curve called out in the numbers-analysis subsection of the parent financials tab.
The deceleration curve is calibrated by archetype: hyper-growth names get a 5-10 percentage-point-per-year glide path, mature compounders converge to GDP-plus-inflation. Visibility-adjusted deceleration is documented in the assumption ledger.
Where the company reports segments, the segment composition is included in the financials section. The competitive-moat tab covers the qualitative drivers (pricing power, switching costs, distribution).
The parent financials tab carries five years of standardized revenue history. For the longer-term trend, the report's appendix logs data provenance and the source dataset identifier.
FAQ
CRM — frequently asked questions
Based on our latest analysis, CRM looks meaningfully undervalued. The current price is $182 versus a composite fair-value midpoint of $237 (range $172–$303), which implies roughly 30.3% upside to the midpoint.
Our composite fair-value range for CRM is $172–$303, with a midpoint of $237. The range is triangulated across multiple valuation models (discounted earnings, forward earnings scenarios, peer multiples, and where applicable owner earnings or reverse DCF) and weighted by reliability for CRM's archetype.
Our current rating for CRM is Strong Buy with a confidence score of 88/100. Strong Buy. The market over-penalizes top-line deceleration while under-appreciating the structural pivot toward margin expansion, massive free cash flow conversion, and aggressive share repurchases. This is research for educational purposes, not personalized investment advice.
The top risks our latest report flags for CRM are: Growth Stagnation; M&A Relapse; AI Displacement. The single biggest risk is Growth Stagnation: Core software markets saturate entirely, permanently capping top-line growth below 5%.
Our current rating for CRM is Strong Buy, issued with a confidence score of 88/100 and a moat score of 9/10. The rating reflects the composite fair-value range ($172–$303) versus the current price of $182.
CRM is classified as a mature compounder stock. Archetype determines how every downstream parameter — discount rate, terminal growth, deceleration curve, terminal multiple, scenario probability weights, scorecard weights, and which valuation models are prioritized — is calibrated for CRM.